Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q2 EPS of ($0.92), $0.07 worse than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.